Treatment with testosterone therapy in type 2 diabetic hypogonadal adult males: a systematic review and meta-analysis

K Kumari, R Kumar, A Memon, B Kumari, M Tehrim… - Clinics and …, 2023 - mdpi.com
Testosterone replacement therapy (TRT) has been used to treat hypogonadal males with
type 2 diabetes mellitus (T2DM) for a long time, despite variable results. This meta-analysis …

[HTML][HTML] Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies

A Kokorovic, AI So, H Serag, C French… - Canadian Urological …, 2021 - ncbi.nlm.nih.gov
2. Methods EmBASE and Medline databases were accessed to identify all relevant articles
focused on adverse events related to ADT from inception to December 2020. The following …

[HTML][HTML] Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism

M de Almeida Ferreira, JA Mendonça - Drugs in context, 2022 - ncbi.nlm.nih.gov
Background Testosterone replacement therapy (TRT) is one of the main lines of treatment
for men with hypogonadism. This study sought to evaluate the influence of TRT in men with …

[HTML][HTML] Метаболические и сердечно-сосудистые особенности течения сахарного диабета 2-го типа у мужчин с гипогонадизмом

ТЮ Демидова, ДВ Скуридина… - Медицинский совет, 2022 - cyberleninka.ru
Введение. Андрогенный дефицит является важным патогенетическим элементом
развития метаболического синдрома и сердечно-сосудистых заболеваний у мужчин …

Testosterone aggravates cerebral vascular injury by reducing plasma HDL levels

T Jin, L Wang, D Li, T Yang, Y Zhou - Open Life Sciences, 2020 - degruyter.com
Testosterone is often used to improve the physiological function. But increased testosterone
levels affect blood lipids and cause inflammation and oxidative stress, which are risk factors …

[HTML][HTML] 基于网络药理学探究桃仁–红花调控动脉粥样硬化斑块稳定性的潜在机制

刘婷, 俞琦 - Pharmacy Information, 2023 - hanspub.org
目的: 探究桃仁–红花调控动脉粥样硬化斑块稳定性的潜在机制. 方法: 对GEO
数据库中的动脉斑块相关数据集进行差异分析, 得到动脉粥样硬化斑块稳定性相关基因 …

Role of Ganoderma lucidum-derived peptide polysaccharides as antioxidants in diabetic patients with metabolic syndrome

AMF Aishaqeena, FA Sonia, AGHS Adji… - AIP Conference …, 2025 - pubs.aip.org
Cardiometabolic syndrome, or often referred to as metabolic syndrome, is a concurrent
metabolic instability that increases the risk of obesity, hyperlipidemia, diabetes …

Adrenal cortical hormones and blood pressure regulation

A Sanders, CJ Fernandez, R Gama - Endocrine Hypertension, 2023 - Elsevier
Adrenal steroid hormones involved in blood pressure (BP) regulation and hypertension via
classical mineralocorticoid or glucocorticoid action are well established. Aldosterone, and …

Minimising Cardiometabolic Risk Factors in Patients with Hypopituitarism

E Armeni, A Grossman - Pituitary Disorders throughout the Life Cycle: A …, 2022 - Springer
Hypopituitarism, irrespective of the underlying cause, is a complicated condition, which
requires careful hormone assessment and optimal replacement therapy. Deficiencies of one …

O desenvolvimento da Síndrome Metabólica em pacientes com Hipogonadismo de início tardio

JP Lounine, JA Aguiar, NRP Campos… - Research, Society and …, 2024 - rsdjournal.org
Introduction: The reduction in serum testosterone levels with age can be associated with an
increase in body fat and a worsening of endocrine-metabolic parameters, culminating in …